Total artificial heart and the hepatobiliary-GI systems

Affiliations

Editorial

Robert M Cole. Ann Cardiothorac Surg. 2020 Mar.

. 2020 Mar;9(2):131-133.

doi: 10.21037/acs.2020.03.03.

¹ Department of Cardiology, Cedars-Sinai Smidt Heart Institute, Los Angeles, CA, USA.

No abstract available

Conflict of interest statement

Conflicts of Interest: The author has no conflicts of interest to declare.

1. Kormos RL, Cowger J, Pagani FD, et al. The Society of Thoracic Surgeons Intermacs database annual report: Evolving indications, outcomes, and scientific partnerships. J Heart Lung Transplant 2019;38:114-26. 10.1016/j.healun.2018.11.013 - DOI - PubMed
1. Arabia FA, Cantor RS, Koehl DA, et al. Interagency registry for mechanically assisted circulatory support report on the total artificial heart. J Heart Lung Transplant 2018;37:1304-12. 10.1016/j.healun.2018.04.004 - DOI - PubMed
1. Dimitriou AM, Dapunt O, Knez I, et al. Liver failure in total artificial heart therapy. J Thorac Dis 2016;8:1546-9. 10.21037/jtd.2016.05.81 - DOI - PMC - PubMed
1. Volod O, Lam LD, Lin G, et al. Role of Thromboelastography Platelet Mapping and International Normalized Ratio in Defining "Normocoagulability" During Anticoagulation for Mechanical Circulatory Support Devices: A Pilot Retrospective Study. ASAIO J 2017;63:24-31. 10.1097/MAT.0000000000000445 - DOI - PubMed
1. van der Merwe J, Paul E, Rosenfeldt FL. Early Gastrointestinal Complications From Ventricular Assist Devices is Increased by Non-Pulsatile Flow. Heart Lung Circ 2020;29:295-300. 10.1016/j.hlc.2019.01.009 - DOI - PubMed